Last Updated 2 December 2022.
6 Vaccines Approved for Use in Kazakhstan
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 149 countries
100 trials in 31 countries
Approval Source: astanatimes.com
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 26 countries
7 trials in 3 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
25 trials in 8 countries
Approval Source: tass.com
-
Research Institute for Biological Safety Problems (RIBSP)
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
Approval Source: reuters.com
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 93 countries
39 trials in 18 countries
Approval Source: astanatimes.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 56 countries
42 trials in 10 countries
Approval Source: astanatimes.com
2 Vaccines in Clinical Trials in Kazakhstan
-
Research Institute for Biological Safety Problems (RIBSP)
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Research Institute for Biological Safety Problems
QazCoVac-P- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country